Patrick D. Walsh - 11 May 2026 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Reporting relationship
Director
Issuer ticker
ANIP
Reported as of
11 May 2026
Net transaction value
-$1,127,120
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 May 2026, 20:22:10 UTC
Prior SEC filing
03 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Patrick D. Walsh, by attorney-in-fact Meredith W. Cook

Key filing fact

Patrick D. Walsh filed Form 4 for ANI PHARMACEUTICALS INC (ANIP) on 13 May 2026.

Key facts

  • This page summarizes Patrick D. Walsh's Form 4 filing for ANI PHARMACEUTICALS INC (ANIP).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 13 May 2026, 20:22.

Change

  • Previous filing in this sequence was filed on 03 Mar 2026.
  • Current net transaction value: -$1,127,120.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001720568 Primary reporting owner

Walsh Patrick D

Relationship
Director
Address
C/O ANI PHARMACEUTICALS, INC., 104 CARNEGIE CENTER, SUITE 300, PRINCETON
Signature
/s/ Patrick D. Walsh, by attorney-in-fact Meredith W. Cook
Signature date
13 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANIP transaction

Common Stock

Sale

Transaction value
$320,820
Shares
-3,973
Change %
-7.6%
Price
$80.75
Shares after
48,432
Date
11 May 2026
Ownership
Direct
ANIP transaction

Common Stock

Sale

Transaction value
$806,300
Shares
-10,000
Change %
-21%
Price
$80.63
Shares after
38,432
Date
13 May 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .